https://doi.org/10.1111/j.1440-1827.2005.01852.x
R
Rieko Nishimura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
1.6K
Citations
23
h-index
47
i10-index
Rieko Nishimura is an academic researcher from National Hospital Organization. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & HER2/EGFR in Cancer Research. The author has an h-index of 23, co-authored 109 publications.
ORCID: 0000-0003-2388-290XPapers by this author
worksAdenoid basal carcinoma of the uterine cervix: Report of two cases with reference to adenosquamous carcinoma
2005 · Pathology International · 21 citations
Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone
2012 · Breast Cancer · 20 citations
https://doi.org/10.1007/s12282-012-0380-z
HER 2 immunohistochemistry for breast cancer cell blocks can be used in the same way as that used for histological specimens
2016 · Diagnostic Cytopathology · 17 citations
https://doi.org/10.1002/dc.23433
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence
2015 · European Journal of Surgical Oncology · 16 citations
https://doi.org/10.1016/j.ejso.2015.01.030
Correlation of HER2 gene status assessment by fluorescence in situ hybridization between histological sections and cytological specimens of breast cancer
2014 · Breast Cancer · 9 citations
https://doi.org/10.1007/s12282-014-0552-0
Primary gastric low-grade fibromyxoid sarcoma with FUS-CREB3L1 fusion – A hitherto undescribed origin of Evans tumor
2017 · Human Pathology Case Reports · 4 citations
https://doi.org/10.1016/j.ehpc.2017.10.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat